Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001055726-25-000032
Filing Date
2025-05-21
Accepted
2025-05-21 16:57:10
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747861024.html 4  
1 FORM 4 wk-form4_1747861024.xml 4 5179
  Complete submission text file 0001055726-25-000032.txt   6942
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Issuer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 717 BEACOM LANE MERION STATION PA 19066-1603
Business Address
Weiner David B. (Reporting) CIK: 0001669080 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14888 | Film No.: 25973774